Atara Biotherapeutics, Inc
ATRA Real Time Price USDRecent trades of ATRA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ATRA's directors and management
Government lobbying spending instances
-
$30,000 Oct 21, 2024 Issue: Health Issues
-
$30,000 Jul 21, 2024 Issue: Health Issues
-
$30,000 Apr 15, 2024 Issue: Health Issues
-
$60,000 Jul 13, 2023 Issue: Health Issues
-
$60,000 Apr 07, 2023 Issue: Health Issues
-
$60,000 Jan 18, 2023 Issue: Health Issues
-
$60,000 Oct 11, 2022 Issue: Health Issues
-
$60,000 Jul 20, 2022 Issue: Health Issues
-
$60,000 Apr 20, 2022 Issue: Health Issues
-
$60,000 Jan 09, 2022 Issue: Health Issues
-
$60,000 Oct 14, 2021 Issue: Health Issues
-
$60,000 Jul 19, 2021 Issue: Health Issues
-
$40,000 Apr 19, 2021 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ATRA in WallStreetBets Daily Discussion
Recent insights relating to ATRA
Recent picks made for ATRA stock on CNBC
ETFs with the largest estimated holdings in ATRA
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ATRA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.